Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Effectiveness of Recombinant Human Growth Hormone (rhGH) in the Treatment of Patients with Cystic Fibrosis

Slide: 21 of 37

Intermediate End Points and Health Outcomes in rhGH-Treated Patients With CF (3)

This slide summarizes key findings from the systematic review about the correlation of pulmonary function and anthropometrics with  mortality and HRQoL.

Percent predicted FEV1 is found to be a consistent predictor of mortality by multivariate regression analysis, with higher baseline scores or lesser rate of decline linked to better survival rates. Percent predicted FEV1 is also a multivariate predictor for many individual domains of HRQoL questionnaires, but the relationship to overall scores was not determined.